Raymond James Financial Services Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$1.08M Sell
59,707
-4,996
-8% -$90K ﹤0.01% 2113
2024
Q2
$1.05M Sell
64,703
-413
-0.6% -$6.71K ﹤0.01% 2053
2024
Q1
$919K Sell
65,116
-7,810
-11% -$110K ﹤0.01% 2122
2023
Q4
$761K Sell
72,926
-787
-1% -$8.22K ﹤0.01% 2141
2023
Q3
$752K Sell
73,713
-776
-1% -$7.92K ﹤0.01% 2071
2023
Q2
$561K Sell
74,489
-18,775
-20% -$141K ﹤0.01% 2276
2023
Q1
$825K Sell
93,264
-5,664
-6% -$50.1K ﹤0.01% 2028
2022
Q4
$902K Sell
98,928
-1,466
-1% -$13.4K ﹤0.01% 1903
2022
Q3
$810K Sell
100,394
-25,599
-20% -$207K ﹤0.01% 1945
2022
Q2
$947K Buy
125,993
+9,858
+8% +$74.1K ﹤0.01% 1875
2022
Q1
$1.09M Buy
116,135
+8,330
+8% +$78.3K ﹤0.01% 1884
2021
Q4
$864K Sell
107,805
-43,955
-29% -$352K ﹤0.01% 2064
2021
Q3
$1.48M Sell
151,760
-152,111
-50% -$1.48M ﹤0.01% 1680
2021
Q2
$3.01M Sell
303,871
-290,358
-49% -$2.87M 0.01% 1247
2021
Q1
$6.86M Buy
594,229
+26,194
+5% +$302K 0.02% 757
2020
Q4
$5.48M Buy
568,035
+15,825
+3% +$153K 0.01% 796
2020
Q3
$4.98M Buy
552,210
+62,782
+13% +$566K 0.01% 763
2020
Q2
$6.04M Buy
489,428
+25,279
+5% +$312K 0.02% 634
2020
Q1
$4.17M Buy
464,149
+103,888
+29% +$933K 0.02% 586
2019
Q4
$3.53M Buy
360,261
+126,836
+54% +$1.24M 0.01% 869
2019
Q3
$1.61M Sell
233,425
-8,530
-4% -$58.7K 0.01% 1223
2019
Q2
$2.23M Buy
241,955
+182,523
+307% +$1.68M 0.01% 1046
2019
Q1
$932K Sell
59,432
-16,755
-22% -$263K ﹤0.01% 1498
2018
Q4
$1.18M Buy
76,187
+1,497
+2% +$23.1K 0.01% 1178
2018
Q3
$1.61M Sell
74,690
-8,783
-11% -$189K 0.01% 1199
2018
Q2
$2.03M Buy
83,473
+16,946
+25% +$412K 0.01% 1017
2018
Q1
$1.14M Sell
66,527
-2,031
-3% -$34.7K 0.01% 1233
2017
Q4
$1.3M Sell
68,558
-7,520
-10% -$142K 0.01% 1140
2017
Q3
$1.34M Sell
76,078
-83,555
-52% -$1.47M 0.01% 1124
2017
Q2
$5.3M Buy
159,633
+15,038
+10% +$500K 0.04% 491
2017
Q1
$4.64M Buy
144,595
+37,692
+35% +$1.21M 0.04% 510
2016
Q4
$3.88M Sell
106,903
-34,758
-25% -$1.26M 0.03% 521
2016
Q3
$6.52M Buy
141,661
+29,016
+26% +$1.34M 0.06% 361
2016
Q2
$5.66M Buy
112,645
+15,635
+16% +$785K 0.05% 375
2016
Q1
$5.19M Buy
97,010
+7,417
+8% +$397K 0.06% 347
2015
Q4
$5.88M Buy
89,593
+6,661
+8% +$437K 0.07% 324
2015
Q3
$4.68M Buy
+82,932
New +$4.68M 0.08% 299
2013
Q4
Sell
-11,647
Closed -$440K 522
2013
Q3
$440K Sell
11,647
-55,112
-83% -$2.08M 0.03% 418
2013
Q2
$2.62M Buy
+66,759
New +$2.62M 0.08% 310